{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:38:35Z","timestamp":1784133515461,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,16]]},"DOI":"10.7759\/cureus.84259","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T06:16:21Z","timestamp":1747462581000},"source":"Crossref","is-referenced-by-count":1,"title":["Role of Fasting in the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Systematic Review of Clinical Trials"],"prefix":"10.7759","author":[{"given":"Ryan  R","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga Spandana","family":"Battula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timmie","family":"Chay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirath","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabina","family":"Dumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivarshini","family":"Maddukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13111852","article-title":"Non-invasive imaging methods to evaluate non-alcoholic fatty liver disease with fat quantification: a review","volume":"13","author":"Jang W","year":"2023","unstructured":"Jang W, Song JS. Non-invasive imaging methods to evaluate non-alcoholic fatty liver disease with fat quantification: a review. Diagnostics (Basel). 2023, 13:1852. 10.3390\/diagnostics13111852","journal-title":"Diagnostics (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329998","article-title":"Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD","volume":"72","author":"Marjot T","year":"2023","unstructured":"Marjot T, Tomlinson JW, Hodson L, Ray DW. Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD. Gut. 2023, 72:1607-19. 10.1136\/gutjnl-2023-329998","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2022.115056","article-title":"Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients","volume":"8","author":"Badran H","year":"2022","unstructured":"Badran H, Elsabaawy M, Sakr A, Eltahawy M, Elsayed M, Elsabaawy DM, Abdelkreem M. Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients. Clin Exp Hepatol. 2022, 8:118-24. 10.5114\/ceh.2022.115056","journal-title":"Clin Exp Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000212","article-title":"Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"7","author":"Lange M","year":"2023","unstructured":"Lange M, Nadkarni D, Martin L, Newberry C, Kumar S, Kushner T. Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Hepatol Commun. 2023, 7:0212. 10.1097\/HC9.0000000000000212","journal-title":"Hepatol Commun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47763-8","article-title":"A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease","volume":"9","author":"Johari MI","year":"2019","unstructured":"Johari MI, Yusoff K, Haron J, et al.. A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease. Sci Rep. 2019, 9:11232. 10.1038\/s41598-019-47763-8","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111847","article-title":"Effects of time-restricted feeding (16\/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: a randomized controlled trial","volume":"105","author":"Kord-Varkaneh H","year":"2023","unstructured":"Kord-Varkaneh H, Salehi-Sahlabadi A, Tinsley GM, Santos HO, Hekmatdoost A. Effects of time-restricted feeding (16\/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: a randomized controlled trial. Nutrition. 2023, 105:111847. 10.1016\/j.nut.2022.111847","journal-title":"Nutrition"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S430740","article-title":"The impact of intermittent fasting on non-alcoholic fatty liver disease in older adults: a review of ClinicalTrials.gov registry","volume":"16","author":"Alorfi NM","year":"2023","unstructured":"Alorfi NM, Ashour AM. The impact of intermittent fasting on non-alcoholic fatty liver disease in older adults: a review of ClinicalTrials.gov registry. Diabetes Metab Syndr Obes. 2023, 16:3115-21. 10.2147\/DMSO.S430740","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-25950-0_6","article-title":"Circadian clocks and metabolism","author":"Marcheva B","year":"2013","unstructured":"Marcheva B, Ramsey KM, Peek CB, Affinati A, Maury E, Bass J. Circadian clocks and metabolism. Handb Exp Pharmacol. 2013, 127-55. 10.1007\/978-3-642-25950-0_6","journal-title":"Handb Exp Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12630","article-title":"Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: a pilot, randomized trial","volume":"15","author":"Goss AM","year":"2020","unstructured":"Goss AM, Dowla S, Pendergrass M, et al.. Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: a pilot, randomized trial. Pediatr Obes. 2020, 15:e12630. 10.1111\/ijpo.12630","journal-title":"Pediatr Obes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-024-00968-8","article-title":"A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight\/obese patients with NAFLD: a multicenter randomized controlled trial in China","volume":"23","author":"Liu Z","year":"2024","unstructured":"Liu Z, Jin P, Liu Y, et al.. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight\/obese patients with NAFLD: a multicenter randomized controlled trial in China. Nutr J. 2024, 23:64. 10.1186\/s12937-024-00968-8","journal-title":"Nutr J"},{"key":"ref12","article-title":"Impact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease","volume":"29","author":"Chen J","year":"2020","unstructured":"Chen J, Huang Y, Xie H, et al.. Impact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease. Asia Pac J Clin Nutr. 2020, 29:483-90.","journal-title":"Asia Pac J Clin Nutr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150996","article-title":"Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease","volume":"131","author":"Cohen CC","year":"2021","unstructured":"Cohen CC, Li KW, Alazraki AL, et al.. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease. J Clin Invest. 2021, 131:e150996. 10.1172\/JCI150996","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/nu15234870","article-title":"Time-restricted fasting improves liver steatosis in non-alcoholic fatty liver disease-a single blinded crossover trial","volume":"15","author":"Feehan J","year":"2023","unstructured":"Feehan J, Mack A, Tuck C, et al.. Time-restricted fasting improves liver steatosis in non-alcoholic fatty liver disease-a single blinded crossover trial. Nutrients. 2023, 15:4870. 10.3390\/nu15234870","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.12.001","article-title":"Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: a randomized controlled trial","volume":"35","author":"Ezpeleta M","year":"2023","unstructured":"Ezpeleta M, Gabel K, Cienfuegos S, et al.. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: a randomized controlled trial. Cell Metab. 2023, 35:56-70.e3. 10.1016\/j.cmet.2022.12.001","journal-title":"Cell Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.3513","article-title":"Effects of time-restricted eating on nonalcoholic fatty liver disease: the TREATY-FLD randomized clinical trial","volume":"6","author":"Wei X","year":"2023","unstructured":"Wei X, Lin B, Huang Y, et al.. Effects of time-restricted eating on nonalcoholic fatty liver disease: the TREATY-FLD randomized clinical trial. JAMA Netw Open. 2023, 6:e233513. 10.1001\/jamanetworkopen.2023.3513","journal-title":"JAMA Netw Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-1132-8","article-title":"Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial","volume":"19","author":"Cai H","year":"2019","unstructured":"Cai H, Qin YL, Shi ZY, et al.. Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. BMC Gastroenterol. 2019, 19:219. 10.1186\/s12876-019-1132-8","journal-title":"BMC Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100256","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial","volume":"3","author":"Holmer M","year":"2021","unstructured":"Holmer M, Lindqvist C, Petersson S, et al.. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. JHEP Rep. 2021, 3:100256. 10.1016\/j.jhepr.2021.100256","journal-title":"JHEP Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.948655","article-title":"Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: a randomized controlled trial","volume":"9","author":"Kord Varkaneh H","year":"2022","unstructured":"Kord Varkaneh H, Salehi Sahlabadi A, G\u0103man MA, Rajabnia M, Sedanur Macit-\u00c7elebi M, Santos HO, Hekmatdoost A. Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: a randomized controlled trial. Front Nutr. 2022, 9:948655. 10.3389\/fnut.2022.948655","journal-title":"Front Nutr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/354406-role-of-fasting-in-the-management-of-non-alcoholic-fatty-liver-disease-nafld-a-systematic-review-of-clinical-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T06:16:22Z","timestamp":1747462582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/354406-role-of-fasting-in-the-management-of-non-alcoholic-fatty-liver-disease-nafld-a-systematic-review-of-clinical-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84259","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}